Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response.
Michela LibertiniI MitraW T A van der GraafA B MiahI JudsonR L JonesK ThomasE MoskovicZ SzucsC BensonC MessiouPublished in: Clinical sarcoma research (2018)
No relationship was identified between symptomatic benefit and response by RECIST 1.1 on MRI. Prospective studies in AF should incorporate endpoints focusing on patient symptoms.